No­var­tis and Sam­sung ink five-year, $309M ex­pan­sion to bi­o­log­ics man­u­fac­tur­ing part­ner­ship

Sam­sung Bi­o­log­ics dis­closed Mon­day that it’s sig­nif­i­cant­ly ex­pand­ing a 2022 pact with No­var­tis to help with the Swiss com­pa­ny’s bi­o­log­ics man­u­fac­tur­ing.

The orig­i­nal $81 mil­lion …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER